BioSpace News Archive

Three months post-gene therapy, first patient in Gaucher trial shows reductions in the toxic metabolite plasma lyso-Gb1 and plasma chitotriosidase as compared to baseline when the patient was on ERT Ongoing Fabry disease trials continue to demonstrate sustained durability, with first patient out 3.5 years

KKR, a leading global investment firm, and Duke Rohlen, a 20-year medical device veteran, today announced the formation of Zeus Health (“Zeus”), a $100 million platform focused on investing in and operating a portfolio of emerging medical device companies. Zeus marks the continuation of a long-standing relationship between KKR and Mr. Rohlen. Throughout his career, Mr. Rohlen has successfully led, grown and exite

CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, announced that it is accelerating the expansion of its manufacturing network to deliver pandemic-scale volumes of its COVID-19 vaccine candidate, CVnCoV.

Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it has received the final meeting minutes from the U.S. Food and Drug Administration (FDA) following the Company’s recent Type A meeting to discuss the steps required for resubmission of the New Drug Application (NDA) for VP-102 for the treatment of mollus

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors and other cancers, today announced its chief executive officer, David Arthur, will participate in A.G.P.’s Virtual Healthcare Symposium on Thursday, November 19, 2020. Mr. Arthur will host virtual one-on-one meetings with investors registered to attend the conference to discu

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced first-ever, industry-wide principles on clinical trial diversity. The principles focus on four main areas: building trust and acknowledging the historic mistrust of clinical trials within Black and Brown communities, reducing barriers to clinical trial a

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on the final design of its FORWARD study, a pivotal Phase 3 clini

Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, announced separate 5-year agreements with two prominent post-acute care providers, Vibra Healthcare and Ernest Health.

StageZero Life Sciences Ltd. announces that it is restating its financial statements for the three and six months ended June 30, 2020, along with a corresponding restated management discussion and analysis, and will be delayed in filing its interim financial statements for the three and nine months ended September 30, 2020 pending an accounting review, along with the corresponding management discussion and analysis.

Wilburn Medical USA announces the availability of AccessBio’s CareStart COVID-19 rapid antigen tests in stock for Medical Providers. Here’s more on it.